PH3 smells fishy..

It doesn't pass the sniff test. What i would like to see is the phase 3 data in full and not just the end point. Did the sozinibercept outperform at any period throughout the trial? Did they really use 2mg, seems to reflect the lower dosage result relative to the control from Ph2. How can control perform so well? Were all patients given the same mixture.. Where was data stored during the trial....